Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math.

Giordano, Frank A; Veldwijk, Marlon R; Herskind, Carsten; Wenz, Frederik

Giordano, Frank A; Veldwijk, Marlon R; Herskind, Carsten; Wenz, Frederik.

Afiliação

Giordano FA; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. frank.giordano@umm.de.
Veldwijk MR; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Herskind C; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Wenz F; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Strahlenther Onkol ; 194(10): 873-875, 2018 10.

Article em En | MEDLINE | ID: mdl-30030581

Assuntos

Mutação; Carga Tumoral; Humanos; Neoplasias

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carga Tumoral / Mutação Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google